FolioMetrix’s Abiomed Inc ABMD Stock Holding History

FolioMetrix’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,900	Closed	-$279K	–	272
2015 Q1	$279K	Buy	+3,900	New	+$212K	0.14%	120

Other funds holding ABMD

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

FolioMetrix's ABMD Position: Q2 2015 in Review

FolioMetrix sold out of Abiomed Inc (ABMD) in Q2 2015, closing a stake of 3,900 shares — an estimated $279K sold.

FolioMetrix first reported a position in ABMD in Q1 2015 and held it in 1 quarter. The position peaked at $279K in Q1 2015. 227 funds tracked by Wall St. Rank hold ABMD as of Q2 2015.

FolioMetrix reported no remaining Abiomed Inc position as of Q2 2015 after selling out during the quarter.
FolioMetrix sold 3,900 Abiomed Inc shares in Q2 2015, an estimated $279K.
FolioMetrix first reported a position in Abiomed Inc in Q1 2015 and held it in 1 quarter.
FolioMetrix's Abiomed Inc position peaked at $279K in Q1 2015.
227 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.